Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The bacterial ribosome 30S subunit A-site, also known as the decoding site, is a critical functional region within the small ribosomal subunit of prokaryotes responsible for ensuring the fidelity of protein synthesis (Wikipedia, 2024). It is primarily composed of the 16S ribosomal RNA (rRNA), where highly conserved adenine residues (A1492 and A1493) monitor the base-pairing between the mRNA codon and the tRNA anticodon (Carter et al., Nature, 2000). This site is the primary target for several major classes of antibiotics, including aminoglycosides and tetracyclines (Patsnap, 2024). Aminoglycosides bind to the A-site and induce a conformational change that stabilizes the binding of near-cognate tRNAs, leading to mRNA misreading and the production of erroneous, toxic proteins (NIH, 2018). Tetracyclines, in contrast, bind to the A-site to sterically block the entry of aminoacyl-tRNAs, thereby halting the elongation phase of translation (NIH, 2018). Due to the structural similarity between bacterial and human mitochondrial ribosomes, drugs targeting this site can cause significant safety concerns, such as ototoxicity and nephrotoxicity (Gosset.ai, 2026).
Aminoglycosides bind to the 16S rRNA A-site, inducing a conformational change in residues A1492 and A1493 that stabilizes near-cognate tRNA binding, leading to mRNA misreading and the production of faulty proteins (Carter et al., Nature, 2000). Tetracyclines bind to the A-site to sterically block the entry of aminoacyl-tRNA, thereby inhibiting the elongation phase of protein synthesis (NIH, 2018).
11 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial ribosome 30S subunit A-site (30S A-site).